ANGIRID MR 35 mg is a tablet containing trimetazidine dihydrochloride 35 mg (modified release). It is an anti-anginal medicine used to improve the energy metabolism of heart cells and help reduce symptoms of stable angina.
Uses:
Treatment of stable angina pectoris
Helps reduce the frequency of angina attacks
Improves heart muscle energy utilization
Used as an add-on therapy with other anti-anginal medicines when symptoms are not adequately controlled
Dose:
Adults: Usually 35 mg twice daily with meals or as directed by a physician
Swallow the tablet whole; do not crush or chew
Take regularly for best effect
Dose adjustment may be required in elderly patients or those with kidney problems
Follow the prescribed dose and duration as advised by a healthcare professional